PRIMARY LIVER CANCER
Clinical trials for PRIMARY LIVER CANCER explained in plain language.
Never miss a new study
Get alerted when new PRIMARY LIVER CANCER trials appear
Sign up with your email to follow new studies for PRIMARY LIVER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Sound waves zapping liver tumors: new study tracks success in 5,000 patients
Disease control Recruiting nowThis observational study will follow up to 5,000 people with liver tumors who are treated with the HistoSonics Edison system, which uses sound waves (histotripsy) to destroy tumors without needles or surgery. The main goal is to see how well the treatment works right after the pr…
Matched conditions: PRIMARY LIVER CANCER
Sponsor: HistoSonics, Inc. • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
Blood test may spot liver cancer comeback sooner
Diagnosis Recruiting nowThis study is testing a new blood test that looks for specific gene changes (methylation) to see if it can detect when primary liver cancer comes back after treatment. Researchers will compare the test results with standard doctor evaluations in 500 patients who had surgery, tran…
Matched conditions: PRIMARY LIVER CANCER
Sponsor: Wuhan Ammunition Life-tech Co., Ltd • Aim: Diagnosis
Last updated May 17, 2026 02:01 UTC
-
New ultrasound method could speed up liver cancer treatment decisions
Diagnosis Recruiting nowThis study tests whether contrast-enhanced ultrasound (CEUS) can more accurately show if liver cancer has been killed by a targeted radiation treatment called TARE. Standard CT or MRI scans often take months to give clear results, delaying next steps. Researchers will enroll 30 a…
Matched conditions: PRIMARY LIVER CANCER
Phase: PHASE2 • Sponsor: Thomas Jefferson University • Aim: Diagnosis
Last updated May 14, 2026 12:02 UTC
-
Blood test breakthrough: AI-Powered exosome analysis could end liver cancer guesswork
Diagnosis Recruiting nowThis study aims to develop a blood test that uses tiny particles called exosomes and machine learning to help doctors accurately tell apart two common types of liver cancer—hepatocellular carcinoma and cholangiocarcinoma—before surgery. Researchers will collect blood samples from…
Matched conditions: PRIMARY LIVER CANCER
Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated May 13, 2026 16:00 UTC